A Multicenter, Open-Label, Randomized, Two-Arm Study of Irinotecan (CPT-11) Versus the Combination of Oxaliplatin + Irinotecan (CPT-11) as Second-Line Treatment of Metastatic Colorectal Carcinoma.
Phase of Trial: Phase III
Latest Information Update: 18 Dec 2013
At a glance
- Drugs Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Registrational; Therapeutic Use
- 18 Dec 2013 Last checked against ClinicalTrials.gov record.
- 12 Sep 2005 New trial record.